Samson, Andre L. http://orcid.org/0000-0002-0637-2716
Zhang, Ying
Geoghegan, Niall D.
Gavin, Xavier J.
Davies, Katherine A. http://orcid.org/0000-0002-4423-4664
Mlodzianoski, Michael J. http://orcid.org/0000-0002-3510-9167
Whitehead, Lachlan W. http://orcid.org/0000-0002-4388-9642
Frank, Daniel
Garnish, Sarah E.
Fitzgibbon, Cheree
Hempel, Anne
Young, Samuel N.
Jacobsen, Annette V. http://orcid.org/0000-0003-0252-7685
Cawthorne, Wayne
Petrie, Emma J.
Faux, Maree C.
Shield-Artin, Kristy
Lalaoui, Najoua http://orcid.org/0000-0002-0165-3324
Hildebrand, Joanne M. http://orcid.org/0000-0002-1456-2042
Silke, John http://orcid.org/0000-0002-7611-5774
Rogers, Kelly L.
Lessene, Guillaume http://orcid.org/0000-0002-1193-8147
Hawkins, Edwin D. http://orcid.org/0000-0002-3686-8261
Murphy, James M. http://orcid.org/0000-0003-0195-3949
Funding for this research was provided by:
Cass Foundation
Department of Health | National Health and Medical Research Council (1124737, 1105023)
Article History
Received: 7 April 2020
Accepted: 27 May 2020
First Online: 19 June 2020
Competing interests
: A.L.S., Y.Z., K.A.D., C.F., A.H., S.N.Y., E.J.P., J.M.H., J.S., G.L. and J.M.M. contribute to a project developing necroptosis inhibitors in collaboration with Anaxis Pharma. The other authors declare no competing interests.